Jila Masrour Roudsari1, Soleiman Mahjoub. 1. Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran.
Abstract
BACKGROUND: Bone-specific alkaline phosphatase (BAP) is synthesized by the osteoblasts and is presumed to be involved in the calcification of bone matrix, though its precise role in the formation process is unknown. The aim of the present study was to measure the BAP activity in Paget's and normal specimens by two different techniques. METHODS: Total ALP (TAP) as well as BAP activity-measuring tests were repeatedly undertaken at different times during the day and different days on the serum samples (inter and intra assay). Precision and repeatability of the phenylalanine inhibition (PHI) and heat inactivation (HI) techniques were approved during ten times repetition of all the tests on two normal samples besides one sample from Paget's disease of bone. The measurement of TAP and BAP activities was also carried out on 50 serum samples from normal adults using the standard IFCC-AACC and the established methods, respectively. RESULTS: Coefficients of Variation (CV) for intra-assay of BAP were 2.33% and 3.16% by HI and PHI methods, respectively. Also, the inter-assay CV of BAP was 2.87% and 3.49% for mentioned methods in Paget's sample, respectively. In addition, the correlation of HI and PHI methods was found to be r= +0.873 for bone-specific isoenzyme. CONCLUSION: Regarding the appropriate precision, repeatability and correlation of HI and PHI techniques, as well as their cost effectiveness can be of use in the quantification of bone alkaline phosphatase isoenzyme activity, especially when bone is involved.
BACKGROUND: Bone-specific alkaline phosphatase (BAP) is synthesized by the osteoblasts and is presumed to be involved in the calcification of bone matrix, though its precise role in the formation process is unknown. The aim of the present study was to measure the BAP activity in Paget's and normal specimens by two different techniques. METHODS: Total ALP (TAP) as well as BAP activity-measuring tests were repeatedly undertaken at different times during the day and different days on the serum samples (inter and intra assay). Precision and repeatability of the phenylalanine inhibition (PHI) and heat inactivation (HI) techniques were approved during ten times repetition of all the tests on two normal samples besides one sample from Paget's disease of bone. The measurement of TAP and BAP activities was also carried out on 50 serum samples from normal adults using the standard IFCC-AACC and the established methods, respectively. RESULTS: Coefficients of Variation (CV) for intra-assay of BAP were 2.33% and 3.16% by HI and PHI methods, respectively. Also, the inter-assay CV of BAP was 2.87% and 3.49% for mentioned methods in Paget's sample, respectively. In addition, the correlation of HI and PHI methods was found to be r= +0.873 for bone-specific isoenzyme. CONCLUSION: Regarding the appropriate precision, repeatability and correlation of HI and PHI techniques, as well as their cost effectiveness can be of use in the quantification of bone alkaline phosphatase isoenzyme activity, especially when bone is involved.
Authors: H Tobiume; S Kanzaki; S Hida; T Ono; T Moriwake; S Yamauchi; H Tanaka; Y Seino Journal: J Clin Endocrinol Metab Date: 1997-07 Impact factor: 5.958
Authors: Sana Mahtab; Chris Scott; Nana Akua A Asafu-Agyei; Takwanisa Machemedze; Lisa Frigati; Landon Myer; Heather J Zar Journal: AIDS Date: 2020-11-15 Impact factor: 4.632
Authors: José A Camassa; Camila C Diogo; João P A Bordelo; Marília de A Bonelli; Carlos A Viegas; Jorge T Azevedo; Nuno Dourado; Isabel R Dias Journal: BMC Vet Res Date: 2017-08-15 Impact factor: 2.741
Authors: Hyung Keun Kim; Jun Sik Lee; Ji Hyun Kim; Jong Keun Seon; Kyung Soon Park; Myung Ho Jeong; Taek Rim Yoon Journal: Exp Mol Med Date: 2017-05-12 Impact factor: 8.718
Authors: Connie Shao; Christine Shen; Emily Lu; Rex C Haydon; Hue H Luu; Aravind Athiviraham; Tong-Chuan He; Michael J Lee Journal: Genes Dis Date: 2015-09-30
Authors: Bongkyun Park; Hae Seong Song; Jeong Eun Kwon; Se Min Cho; Seon-A Jang; Mi Yeon Kim; Se Chan Kang Journal: BMC Complement Altern Med Date: 2017-12-20 Impact factor: 3.659